Building Global Healthcare Through Innovation, Quality & Trust

Taj Medico India Limited is a fast-growing pharmaceutical company committed to manufacturing, exporting, and supplying high-quality pharmaceutical formulations to healthcare markets worldwide. The company’s journey reflects continuous innovation, regulatory excellence, and a strong commitment to affordable healthcare solutions.

Founded with a vision to improve access to quality medicines, Taj Medico India Limited has evolved into an integrated pharmaceutical organization with expertise in formulation development, manufacturing, regulatory support, exports, and contract manufacturing services.


1995 – Foundation of the Enterprise

The origins of Taj Medico India Limited began in 1995 with the establishment of a pharmaceutical trading and distribution business dedicated to supplying affordable and quality generic medicines across India.

From the beginning, the organization focused on:

  • Affordable healthcare accessibility
  • Ethical pharmaceutical practices
  • Regulatory compliance
  • Standardized quality systems
  • Long-term healthcare partnerships

This early foundation helped create a strong reputation in pharmaceutical trading and healthcare distribution.


2004 – Expansion into Pharmaceutical Manufacturing

As demand increased, the organization expanded into pharmaceutical manufacturing and product development. This period marked the beginning of:

  • Pharmaceutical formulation development
  • Regulatory documentation systems
  • Product registration support
  • International business expansion
  • Research and development activities

The company strengthened its infrastructure and laid the foundation for future export-oriented pharmaceutical operations.


2007 – Growth in the Indian Pharmaceutical Market

Taj Medico India Limited expanded its domestic pharmaceutical operations across India through:

  • Distribution networks
  • Stockists and wholesalers
  • Institutional supplies
  • PCD pharma franchise operations
  • Ethical marketing divisions

The company introduced a diversified portfolio of branded generic medicines across therapeutic categories such as:

  • Cardiology
  • Gastroenterology
  • Neurology
  • Anti-Infective medicines
  • Pain management
  • General healthcare

This expansion established the company’s growing presence in the Indian pharmaceutical market.


2008 – Entry into International Export Markets

The company began exporting pharmaceutical formulations to international markets with a focus on regulated and semi-regulated regions.

Key developments during this phase included:

  • Product registrations in overseas markets
  • Regulatory dossier preparation
  • International pharmaceutical partnerships
  • Expansion into emerging healthcare markets
  • Strengthening export documentation systems

This marked the beginning of Taj Medico India Limited’s global pharmaceutical expansion strategy.


2011 – Establishment of Modern Manufacturing Facilities

Taj Medico India Limited strengthened its manufacturing capabilities by establishing advanced pharmaceutical production facilities in Gujarat, India.

The facilities were developed with modern pharmaceutical infrastructure designed for:

  • Tablets
  • Capsules
  • Oral powders
  • Sachets
  • Creams and ointments
  • Specialty pharmaceutical formulations

Manufacturing Infrastructure Highlights

  • Modern production blocks
  • Quality Control Laboratories
  • Quality Assurance Departments
  • HVAC-controlled production areas
  • Stability testing systems
  • Research and Development support

The manufacturing operations were designed in compliance with internationally recognized pharmaceutical quality standards.


2014 – Corporate Expansion and International Operations

The company expanded its commercial and regulatory operations to support growing domestic and international business activities.

Major focus areas included:

  • International tender participation
  • Export business development
  • Regulatory affairs management
  • Strategic partnerships
  • Product licensing opportunities
  • Third-party manufacturing collaborations

This phase helped strengthen the company’s position in global pharmaceutical markets.


2014–2018 – Manufacturing Network Expansion

To meet increasing market demand, Taj Medico India Limited expanded its pharmaceutical manufacturing network through strategic collaborations and contract manufacturing partnerships across India.

During this period, the company:

  • Expanded product portfolios
  • Increased manufacturing capacities
  • Strengthened supply chain operations
  • Enhanced quality systems
  • Improved regulatory compliance support

The company continued building strong partnerships with healthcare organizations and pharmaceutical distributors.


2019 – Healthcare Support During Global Challenges

During global healthcare emergencies, Taj Medico India Limited focused on ensuring continuous pharmaceutical supply and supporting healthcare systems through reliable manufacturing and distribution operations.

The company strengthened:

  • Supply chain management
  • Manufacturing continuity
  • Regulatory coordination
  • Quality assurance systems
  • Essential medicine availability

This demonstrated the company’s operational strength and commitment to public healthcare support.


2021 – Investment in Advanced Pharmaceutical Infrastructure

Taj Medico India Limited continued investing in advanced pharmaceutical manufacturing and research infrastructure to support future growth and international market expansion.

The company focused on:

  • Facility modernization
  • Advanced production systems
  • Research and development
  • Quality enhancement programs
  • Export compliance systems

These developments strengthened the company’s long-term pharmaceutical capabilities.


2022 – Manufacturing Modernization and Compliance Enhancement

Manufacturing facilities underwent modernization and process improvements aligned with international pharmaceutical standards.

Upgrades included:

  • Advanced cleanroom systems
  • Improved production technologies
  • Enhanced quality monitoring systems
  • Digital documentation support
  • Regulatory compliance improvements

These enhancements supported the company’s growing export and regulatory objectives.


2025 – Expansion Toward Future Global Growth

Taj Medico India Limited continues to expand its pharmaceutical operations through:

  • Advanced pharmaceutical manufacturing
  • International business development
  • Contract manufacturing services
  • Product registration support
  • Research and innovation
  • Strategic healthcare partnerships

The company remains focused on delivering affordable, high-quality pharmaceutical products to healthcare markets worldwide.


Core Business Areas

Pharmaceutical Manufacturing

Manufacturing of tablets, capsules, sachets, creams, ointments, and specialty formulations.

Contract Manufacturing

Third-party manufacturing and private label pharmaceutical production.

Exports

Global supply of pharmaceutical formulations to international healthcare markets.

Regulatory Support

Product registration documentation and regulatory assistance for export markets.

PCD Pharma Franchise

Distribution and franchise support across multiple healthcare segments.


Commitment to Quality

Taj Medico India Limited follows strict quality systems designed to ensure:

  • Product safety
  • Manufacturing consistency
  • Regulatory compliance
  • International quality standards
  • Customer satisfaction

The company operates with a strong commitment to ethical pharmaceutical practices and healthcare excellence.


Vision for the Future

Taj Medico India Limited aims to become a globally recognized pharmaceutical organization by continuously investing in:

  • Innovation
  • Manufacturing excellence
  • Regulatory capabilities
  • Healthcare accessibility
  • Sustainable pharmaceutical development

With a customer-focused approach and expanding global presence, the company continues working toward improving healthcare outcomes worldwide.


Contact Information

Corporate Office

TAJ MEDICO INDIA LIMITED
Mumbai & Gujarat, India

Manufacturing Facility

Plot No. 1019, Village Sarigam,
G.I.D.C. Road No. 10,
District Valsad, Gujarat – 396155, India

Website

www.tajmedico.com